Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000080438 | SCV000112340 | benign | not specified | 2015-12-16 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000080438 | SCV000168165 | benign | not specified | 2014-03-24 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Laboratory for Molecular Medicine, |
RCV000080438 | SCV000268944 | benign | not specified | 2015-01-13 | criteria provided, single submitter | clinical testing | p.Thr409Ser in exon 11 of DMD: This variant is not expected to have clinical sig nificance because it has been identified in 3.7% (140/3833) of African American chromosomes by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/ EVS/; dbSNP rs34155804). |
Invitae | RCV001082086 | SCV000288040 | benign | Duchenne muscular dystrophy | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000080438 | SCV000309920 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000392921 | SCV000482278 | benign | Dilated cardiomyopathy 3B | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
ARUP Laboratories, |
RCV000755250 | SCV000603338 | benign | not provided | 2023-11-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000621873 | SCV000736384 | benign | Cardiovascular phenotype | 2015-11-12 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Center for Advanced Laboratory Medicine, |
RCV000853048 | SCV000995805 | benign | Hypertrophic cardiomyopathy | 2019-06-03 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000755250 | SCV001143741 | benign | not provided | 2018-10-22 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000080438 | SCV003929346 | likely benign | not specified | 2023-04-10 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001826725 | SCV002090394 | likely benign | Becker muscular dystrophy; Duchenne muscular dystrophy; Cardiomyopathy; Dystrophin deficiency | 2017-04-20 | no assertion criteria provided | clinical testing |